Advertisement

Topics

New Novartis Entresto® real world evidence data shows beneficial impact on quality of life in people living with heart failure

14:30 EST 12 Nov 2017 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Novartis International AG / New Novartis Entresto® real world evidence data shows beneficial impact on quality of life in people living with heart failure . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for th...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "New Novartis Entresto® real world evidence data shows beneficial impact on quality of life in people living with heart failure"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...